 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > InKine Pharmaceutical Company, Inc.
 |
InKine Pharmaceutical Company, Inc. |
 |
 |
 |
PROFILE |
 |
InKine Pharmaceutical isn't inclined to slack in drug development. Formerly focused on developing drugs from plants, the firm now buys rights to drugs with specific targets and further develops them. Development-stage InKine's Visicol is an FDA-approved purgative tablet used to clean the colon before a colonoscopy. Other products in development include its thrombospondin technology intended to prevent the spread of cancerous tumors. InKine has a series of Fc receptor regulators to treat such autoimmune diseases as rheumatoid arthritis, lupus, asthma, and idiopathic thrombocytopenic purpura, or ITP, which affects the blood's ability to clot. InKine is seeking development partnerships with larger drug firms.
COMPETITION |
 |
Boston Life Sciences, Inc. (BLSI)
EntreMed, Inc. (ENMD)
La Jolla Pharmaceutical Company (LJPC)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: 0.0%
KEY PEOPLE |
 |
Leonard S. Jacob
CEO
Robert F. Apple
CFO
CONTACT INFO |
 |
1720 Walton Rd., Sentry Park E., Ste. 200
Blue Bell, PA 19422
US
Phone: 610-260-9350
Fax: 610-260-9355
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |